Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC)

This is an open parallel design randomized trial of amiodarone plus a beta blocker vs a beta blocker alone vs sotalol for the prevention of ICD shocks in patients receiving an ICD for spontaneous or inducible ventricular tachycardia or fibrillation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Ventricular Tachycardia Arrhythmias, Cardiac Cardiac Conduction System Disease Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Tachycardia Tachycardia, Ventricular

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

McMaster University

Hamilton, Ontario, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

spontaneous or inducible ventricular tachycardia or fibrillation -

Exclusion criteria

Treatment and study plan

amiodarone beta blocker sotalol

Drug

Primary outcomes

ICD shock for any cause

Sponsors and collaborators

Lead sponsor

Connolly, Stuart, M.D.

Indiv

Collaborators

Abbott Medical Devices

Registry information

Important dates

Study start: 2001
Study completion: 2004
First posted: Nov 24, 2005
Registry last updated: Jul 27, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed